Filing Details
- Accession Number:
- 0001127602-18-001566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-10 17:40:24
- Reporting Period:
- 2018-01-09
- Accepted Time:
- 2018-01-10 17:40:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341125 | Richard Kuntz | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Srvp & Chief Scien, Clin, Reg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2018-01-09 | 35,492 | $37.53 | 149,761 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2018-01-09 | 45,872 | $34.88 | 195,633 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2018-01-09 | 78,526 | $86.21 | 117,107 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-01-09 | 35,492 | $0.00 | 35,492 | $37.53 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-01-09 | 45,872 | $0.00 | 45,872 | $34.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-08-02 | No | 4 | M | Direct | |
0 | 2021-08-01 | No | 4 | M | Direct |
Footnotes
- This balance increased by 324 shares due to exempt transactions such as dividend reinvestment.
- The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $86.12 to $86.26, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
- This option to purchase 35,492 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 35,492 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- This option to purchase 45,872 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 45,872 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.